ZA908892B - New polypeptide compound and a process for preparation thereof - Google Patents

New polypeptide compound and a process for preparation thereof

Info

Publication number
ZA908892B
ZA908892B ZA908892A ZA908892A ZA908892B ZA 908892 B ZA908892 B ZA 908892B ZA 908892 A ZA908892 A ZA 908892A ZA 908892 A ZA908892 A ZA 908892A ZA 908892 B ZA908892 B ZA 908892B
Authority
ZA
South Africa
Prior art keywords
hydrogen
preparation
polypeptide compound
hydroxy
new polypeptide
Prior art date
Application number
ZA908892A
Other languages
English (en)
Inventor
Toshiro Iwamoto
Iwamoto Toshiro
Akihiko Fujie
Fujie Akihiko
Kumiko Nitta
Nitta Kumiko
Yasuhisa Tsurumi
Tsurumi Yasuhisa
Nobuharu Shigematsu
Shigematsu Nobuharu
Chiyoshi Kasahara
Kasahara Chiyoshi
Motohiro Hino
Hino Motohiro
Masakuni Okuhara
Okuhara Masakuni
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of ZA908892B publication Critical patent/ZA908892B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Stringed Musical Instruments (AREA)
  • Compounds Of Unknown Constitution (AREA)
ZA908892A 1989-11-13 1990-11-06 New polypeptide compound and a process for preparation thereof ZA908892B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898925593A GB8925593D0 (en) 1989-11-13 1989-11-13 Fr901379 substance and preparation thereof

Publications (1)

Publication Number Publication Date
ZA908892B true ZA908892B (en) 1991-09-25

Family

ID=10666207

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA908892A ZA908892B (en) 1989-11-13 1990-11-06 New polypeptide compound and a process for preparation thereof

Country Status (19)

Country Link
US (1) US5502033A (de)
EP (1) EP0431350B1 (de)
JP (1) JP3111470B2 (de)
KR (1) KR910009729A (de)
CN (1) CN1051757A (de)
AT (1) ATE125550T1 (de)
AU (1) AU6655790A (de)
CA (1) CA2029766A1 (de)
DE (1) DE69021176T2 (de)
DK (1) DK0431350T3 (de)
ES (1) ES2075115T3 (de)
FI (1) FI905575A0 (de)
GB (1) GB8925593D0 (de)
HU (1) HUT58820A (de)
IE (1) IE904072A1 (de)
IL (1) IL96272A0 (de)
NO (1) NO904904L (de)
PT (1) PT95876A (de)
ZA (1) ZA908892B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5330973A (en) * 1990-03-19 1994-07-19 Merck & Co., Inc. Lipopeptide derivatives
US5386009A (en) * 1990-03-19 1995-01-31 Merck & Co. Inc. Lipopeptide derivatives
IL98506A (en) * 1990-06-18 1996-09-12 Fujisawa Pharmaceutical Co Peptides, of antibiotics, processes for their preparation and pharmaceutical preparations containing them
US5428009A (en) * 1990-07-16 1995-06-27 Merck & Co., Inc. Lipopeptide derivatives
USH1638H (en) * 1990-11-08 1997-03-04 Furuta; Takahisa Use of the polypeptide compound
EP0486011A3 (en) * 1990-11-16 1992-07-15 Fujisawa Pharmaceutical Co., Ltd. Pharmaceutical composition against pneumocystis carinii
US5385884A (en) * 1991-08-27 1995-01-31 Merck & Co. Inc. Lipopeptide derivatives
US5378804A (en) * 1993-03-16 1995-01-03 Merck & Co., Inc. Aza cyclohexapeptide compounds
AU681119B2 (en) * 1993-05-17 1997-08-21 Fujisawa Pharmaceutical Co., Ltd. New polypeptide compound and a process for preparation thereof
US5516757A (en) * 1994-09-16 1996-05-14 Merck & Co., Inc. Semi-synthetic lipopeptides, compositions containing said lipopeptides, and methods of use
US5516756A (en) * 1994-10-31 1996-05-14 Merck & Co., Inc. Aza cyclohexapeptide compounds
DK0805685T3 (da) * 1995-01-26 2001-11-19 Merck & Co Inc Hidtil ukendte antifungale cyclohexapeptider
ATE544851T1 (de) 1996-03-08 2012-02-15 Astellas Pharma Inc Verfahren zur deacylierung von zyklischen lipopeptiden
EP1666587A1 (de) * 1996-06-13 2006-06-07 Astellas Pharma Inc. Zyclische lipopeptid acylase
US5696084A (en) * 1996-08-16 1997-12-09 Abbott Laboratories Amino-lipopetide antifungal agents
AUPO371596A0 (en) * 1996-11-19 1996-12-12 Fujisawa Pharmaceutical Co., Ltd. New compound
AUPO691897A0 (en) * 1997-05-21 1997-06-12 Fujisawa Pharmaceutical Co., Ltd. New compound
US6319757B1 (en) * 1998-07-08 2001-11-20 Caldus Semiconductor, Inc. Adhesion and/or encapsulation of silicon carbide-based semiconductor devices on ceramic substrates
EP1348033A2 (de) * 2000-05-26 2003-10-01 Board of Trustees of the University of Illinois Reagenzien und methoden zum auffinden und zur expressionsmodulierung von genen, die von retinoiden reguliert werden
US20040082757A1 (en) * 2001-02-26 2004-04-29 Katsuhiko Ito Echinocandin derivatives, pharmaceutical compositions containing same and use thereof as drugs
AUPS188302A0 (en) * 2002-04-22 2002-05-30 Fujisawa Pharmaceutical Co., Ltd. Pharmaceutical composition
US7459290B1 (en) 2004-03-30 2008-12-02 Iowa State University Research Foundation, Inc. Methods of using functional 30S subunits
EP2204379A4 (de) 2007-10-29 2010-12-22 Astellas Pharma Inc Polypeptidverbindung
WO2009113661A1 (ja) * 2008-03-14 2009-09-17 アステラス製薬株式会社 環状化合物およびその塩
US8927690B2 (en) * 2010-09-29 2015-01-06 Shanghai Techwell Biopharmaceutical Co., Ltd. Process for purifying cyclolipopeptide compounds or the salts thereof
EP2623611B1 (de) * 2010-09-30 2016-07-13 Shanghai Techwell Biopharmaceutical Co., Ltd Verfahren zur reinigung eines zyklischen lipopeptids oder eines salzes davon
CN102485879A (zh) * 2010-12-03 2012-06-06 上海医药工业研究院 一种用于生产wf11899a的发酵培养基
CN102533551B (zh) * 2010-12-15 2013-10-09 上海天伟生物制药有限公司 一种肽类抗生素的高产菌株及其制备方法和用途
CN102618604B (zh) * 2011-01-31 2014-09-03 上海天伟生物制药有限公司 一种环脂肽化合物的制备方法
CN102952179B (zh) * 2011-08-24 2015-11-25 华北制药集团新药研究开发有限责任公司 一种高纯度米卡芬净前体化合物的制备方法
CN102627688B (zh) 2012-03-30 2014-12-31 上海天伟生物制药有限公司 一种高纯度环肽化合物及其制备方法和用途
CN102627689B (zh) 2012-03-30 2014-08-06 上海天伟生物制药有限公司 一种环肽类化合物的水合物及其制备方法和用途
CN102659930B (zh) 2012-03-30 2014-04-23 上海天伟生物制药有限公司 一种高纯度环肽类物质的晶体及其制备方法和用途
CN103387975A (zh) 2012-05-11 2013-11-13 上海天伟生物制药有限公司 一种固定化环脂肽酰基转移酶及其制备方法和用途
CN103848900B (zh) * 2012-12-04 2015-12-02 上海医药工业研究院 一种从发酵液中分离纯化wf11899a的方法
CN114874919B (zh) * 2022-05-09 2023-06-27 中国科学院青岛生物能源与过程研究所 一株米卡芬净前体fr901379高产菌株及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4287120A (en) * 1979-12-13 1981-09-01 Eli Lilly And Company Derivatives of S31794/F-1 nucleus
US4320052A (en) * 1979-12-13 1982-03-16 Eli Lilly And Company Derivatives of A-30912A nucleus
US4320053A (en) * 1979-12-13 1982-03-16 Eli Lilly And Company Derivatives of A-30912D nucleus
US4322338A (en) * 1979-12-13 1982-03-30 Eli Lilly And Company Derivatives of A-30912B nucleus
CA1182812A (en) * 1979-12-13 1985-02-19 Bernard J. Abbott Process for the preparation of derivatives of cyclic peptide nuclei
CA1159450A (en) * 1979-12-13 1983-12-27 Manuel Debono Process for the preparation of derivatives of cyclic peptide nuclei
EP0311193B1 (de) * 1987-10-07 1993-12-01 Merck & Co. Inc. Fungizides Fermentationsprodukt
DK173802B1 (da) * 1988-09-12 2001-11-05 Merck & Co Inc Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner
US5330973A (en) * 1990-03-19 1994-07-19 Merck & Co., Inc. Lipopeptide derivatives
IL98506A (en) * 1990-06-18 1996-09-12 Fujisawa Pharmaceutical Co Peptides, of antibiotics, processes for their preparation and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
JPH03184921A (ja) 1991-08-12
EP0431350A1 (de) 1991-06-12
HUT58820A (en) 1992-03-30
JP3111470B2 (ja) 2000-11-20
CA2029766A1 (en) 1991-05-14
PT95876A (pt) 1991-09-13
DE69021176D1 (de) 1995-08-31
AU6655790A (en) 1991-05-16
GB8925593D0 (en) 1990-01-04
KR910009729A (ko) 1991-06-28
US5502033A (en) 1996-03-26
IL96272A0 (en) 1991-08-16
DK0431350T3 (da) 1995-09-11
NO904904D0 (no) 1990-11-12
ATE125550T1 (de) 1995-08-15
FI905575A0 (fi) 1990-11-12
DE69021176T2 (de) 1996-01-11
IE904072A1 (en) 1991-05-22
EP0431350B1 (de) 1995-07-26
CN1051757A (zh) 1991-05-29
NO904904L (no) 1991-05-14
ES2075115T3 (es) 1995-10-01
HU907105D0 (en) 1991-05-28

Similar Documents

Publication Publication Date Title
ZA908892B (en) New polypeptide compound and a process for preparation thereof
IL98506A0 (en) Polypeptides,processes for the preparation thereof and pharmaceutical compositions containing the same
HUT68385A (en) Polypeptide and process for producing thereof
HUT59693A (en) Process for producing morpholinyl derivatives of doxorubicin and pharmaceutical compositions containing them
HUT49631A (en) Process for producing peptide derivatives
IL83225A (en) Antibiotic a 42867,process for its production and pharmaceutical compositions containing it
PH20198A (en) Antibiotic a51568 factor a and b,their method of preparation and pharmaceutical composition
EP0444424A3 (en) Bile acid unsaturated derivatives, processes for the preparation thereof and pharmaceutical compositions containing them